Drugs / SOTB07
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00936624 | Jul 2009 → May 2011 | asthma | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01907763 | Jan 2013 → Oct 2015 | asthma | SK Chemicals Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SOTB07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00936624 ↗ |
| Route | Oral | “after oral administration of SOTB07 200mg, 400mg, placebo for 12 weeks.” NCT01907763 ↗ |